Search

Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.

… Tuesday, February 21, 2017 Summary The most effective drugs being tested for head and neck cancers , which target a pathway called PI3K, have dangerous side effects. MSK researchers developed a way to use nanoparticles to deliver these drugs precisely to the tumor site, allowing lower doses to be used

To mark National Cancer Prevention Month this February, MSK shared several tips to help reduce the risk of developing cancer.

… Tuesday, February 16, 2021 Summary Advice supports mission of National Cancer Prevention Month, as COVID-19 pandemic leads to an alarming drop in cancer screenings, diagnoses and treatment nationwide. To mark National Cancer Prevention Month this February, Memorial Sloan Kettering Cancer Center (MSK)

FoundationOne Heme was developed using technology, methods and computational algorithms developed by Foundation Medicine, combined with Memorial Sloan Kettering’s deep and vast expertise in clinical and laboratory research into hematologic malignancies.

… Saturday, December 7, 2013 Foundation Medicine announced today the launch of its second clinical product, FoundationOne™ Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many sarcomas and pediatric cancers. The test has been developed in collaboration

Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey, today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer care services.

… Tuesday, September 5, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) opened a new state-of-the-art outpatient cancer treatment facility in Basking Ridge, New Jersey , today. The new 85,000-square-foot facility incorporates the latest concepts in therapeutic design and offers the most advanced cancer

Learn how the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers at Memorial Sloan Kettering is transforming the experience, care, and outcomes of teens and young adults with cancer.

… Monday, September 27, 2021 Imagine: Just as you’re finding your footing in the real world — graduating school, starting a new job, getting married, building a family — you’re diagnosed with cancer. It sounds implausible, but it happens to 90,000 teens and young adults in America each year. “Nobody is

Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC's new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary setting designed to foster rapid innovations in cancer care.

… Wednesday, July 7, 2010 Image-guided interventions are revolutionizing cancer diagnosis and treatment. MSKCC’s new Center for Image-Guided Intervention (CIGI), which opened in June, offers cancer patients the most advanced, minimally invasive diagnostic and treatment options in a unique multidisciplinary

MSK ranked #17 out of 500 companies and is the second highest ranked hospital.

… Thursday, April 29, 2021 Forbes has named Memorial Sloan Kettering Cancer Center one of America’s Best Employers for Diversity , ranking the organization #17 out of 500 companies, and the second highest ranked hospital. It’s MSK’s second year on the fourth annual list. “At MSK, we’re committed to ensuring

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center in New York and Lund University in Sweden.

… Thursday, February 14, 2008 A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center in New York

Memorial Sloan Kettering “green” committees focus on waste reduction and energy efficiency throughout the institution while donating useful supplies to New York–area nonprofits.

… Tuesday, July 8, 2014 Summary Memorial Sloan Kettering “green” committees focus on waste reduction and energy efficiency throughout the institution while donating useful supplies to New York–area nonprofits. Some 18,000 of New York City’s homebound elderly rely on the meals that are delivered daily to

Jacqueline Barnes, RN, MPH, of Memorial Sloan Kettering Cancer Center and a resident of Roosevelt Island, NY, has been recognized for outstanding patient care with a New York Times Job Market "Tribute to Nurses" award.

… Monday, November 20, 2006 Only Recipient in the Northeast to be Honored out of 500 Nominees Jacqueline Barnes, RN, MPH, of Memorial Sloan Kettering Cancer Center (MSKCC) and a resident of Roosevelt Island, NY, has been recognized for outstanding patient care with a New York Times Job Market “Tribute